- Research Tracker
- Supplement safety
- Vitamin D
What public sources say about the safety of vitamin D: FDA adverse-event reports, NIH guidance on interactions with medicines, and the registered trials that test it.
Interactions and safety, in NIH's words
Vitamin D supplements may interact with medications, and some medications may affect vitamin D levels. These medications include orlistat, statins, steroids, and thiazide diuretics.
Vitamin D supplements may interact with several types of medications. A few examples are provided below. Individuals taking these and other medications on a regular basis should discuss their vitamin D intakes and status with their health care providers.
The weight-loss drug orlistat (Xenical and alli), together with a reduced-fat diet, can reduce the absorption of vitamin D from food and supplements, leading to lower 25(OH)D levels [167-170].
Medicines covered in that section: Orlistat, Statins, Steroids, Thiazide diuretics.
Quoted from the “Interactions with Medications” section: NIH Office of Dietary Supplements, health-professional fact sheet, retrieved 2026-11-16. Read the full page for the complete list and references.
FDA adverse-event reports (CAERS)
Matching rule: reports in the dietary-supplement category where a product marked "suspect" has a brand name containing “VITAMIN D”. Products that contain it without naming it are missed. Reports where it was only taken alongside the suspect product are not counted.
Combination products: 797 of the reports involve only products whose name lists another ingredient, such as calcium or a multivitamin. Their reactions may come from that other ingredient or from the tablet itself, so the reactions below count only the 184 reports where a product is named for vitamin D alone. This split is made from product names and can misfile some products. Most-reported products: Caltrate 600 + Vitamin D (157); Vitamin D (50); Caltrate 600 +Vitamin D (27); Citracal Calcium + D Slow Release 1200 (26); Caltrate 600 + D Plus Mineral (22); Caltrate 600 Plus Chewable (21).
| Most reported reactions (single-ingredient products) | Reports |
|---|---|
| Diarrhoea | 16 |
| Dyspnoea | 15 |
| Vomiting | 14 |
| Headache | 10 |
| Hypersensitivity | 10 |
| Blood calcium increased | 9 |
| Dizziness | 9 |
| Nausea | 9 |
| Malaise | 8 |
| Muscle spasms | 8 |
| Choking | 8 |
| Dehydration | 7 |
Outcomes recorded in these reports (a report can have several): Other Serious or Important Medical Event (108), Hospitalization (63), Visited a Health Care Provider (40), Visited Emergency Room (35), Other Serious Outcome (27), Life Threatening (18), Disability (13), Other Outcome (8).
Source: openFDA food and supplement adverse events (CAERS), retrieved 2026-11-16.
Registered trials
392 trials in the non-drug evidence map test this class of supplement. Trials with posted results are listed first; each shows the condition it was registered for. A trial testing it in one condition says nothing about another.
- Randomized Trial: Maternal Vitamin D Supplementation to Prevent Childhood Asthma (VDAART) Completed Results posted
- Vitamin D in Preschoolers With Viral-induced Asthma Completed Results posted
- Vitamin D Oral Replacement in Asthma Completed Results posted
- Development of Human Nasal Challenge Models With Microbial Constituents and Grass Pollen Completed Results posted
- Daily Vitamin D for Sickle-cell Respiratory Complications Completed Results posted
- Vitamin D for Sickle-cell Respiratory Complications Completed Results posted
- Personalized Treatment Algorithms for Difficult-to-treat Asthma Completed Results posted
- Efficacy of Calcifediol Supplementation in Asthma Control in Asthmatic Patients With Vitamin D Deficiency (ACViD) Completed Results posted
- Study of the Effect of Vitamin D as an Add-on Therapy to Corticosteroids in Asthma Completed Results posted
- Analysis of Response of Subjects With Atopic Dermatitis or Psoriasis to Oral Vitamin D3 Completed Results posted
- Vitamin D Supplementation for Bipolar Depression Completed Results posted
- Safety, Feasibility and Efficacy of Vitamin D Supplementation in Women With Metastatic Breast Cancer (SAFE-D) Completed Results posted
- Vitamin D3 for Aromatase Inhibitor Induced Arthralgias Completed Results posted
- Development of Vitamin D as a Therapy for Breast Cancer - Phase 2 Completed Results posted
- Study of Vitamin D for Premenopausal Women at High Risk for Breast Cancer Completed Results posted
- Vitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole For Stage I-III Breast Cancer Completed Results posted
- Modulation of Breast Cancer Risk Biomarkers by High Dose Vitamin D Completed Results posted
- Exemestane and Celecoxib in Postmenopausal Women at High Risk for Breast Cancer Completed Results posted
- Vitamin D Supplementation in RNA-seq Profiles of Single-core Prostate Samples, Among Veterans Completed Results posted
- A Study to Evaluate the Effect of Vitamin D on PFS in Indolent Non-Hodgkin's Lymphoma Completed Results posted